Orthofix board member Keith Valentine resigns; interim CEO gets $825k base, $1.5M RSUs

Orthofix Medical Inc.

Keith C. Valentine resigns from Board; notes disagreement with termination for cause of Valentine and others on Sept 11.
Board reduces size from nine to eight directors effective immediately.
Interim CEO Burzik receives $825k base salary, 110% bonus target, $100k after-tax cash bonus for relocation.
Burzik granted $1.5M RSUs vesting 90 days after a successor CEO assumes office.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Keith C. Valentine

Director

OFIX · Orthofix Medical Inc.

Effective: 2023-10-04
Filed: October 5, 2023, 7:59 PM ET

On October 4, 2023, Keith C. Valentine resigned as a member of the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Keith C. Valentine resigned as Director at Orthofix Medical Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 4, 2023, Keith C. Valentine resigned as a member of the Board of Directors (the “Board”) of Orthofix Medical Inc. (the “Company”).

View on SEC.gov

Orthofix Medical Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-052018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.